Yingshi Biotech

应世生物

Yingshi Biotech

Biotech/Healthcare

InxMed is a clinical-stage drug developer that uses disease biology as the basis for innovation. It is building a best-in-class combination therapy development strategy and a platform capable of rapid clinical translation and proof of concept, with the goal of becoming a globally leading…

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01